Table of Content - Fragment-Based Drug Discovery Market Expected to Grow at 11.7% by 2032

Fragment-Based Drug Discovery Market By Component (Fragment Screening, Fragment Optimization), By Application (Oncology, Central Nervous System (CNS) Disorders, Infectious Diseases, Cardiovascular Diseases, Metabolic Disorders, Inflammation & Autoimmune Diseases), By End-User (Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs)) - Growth, Share, Opportunities & Competitive Analysis, 2024 - 2032

20 Jul 2023 Format

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Fragment-Based Drug Discovery Market
2.2. Global Fragment-Based Drug Discovery Market, By Component, 2023 (US$ Million)
2.3. Global Fragment-Based Drug Discovery Market, By Application, 2023 (US$ Million)
2.4. Global Fragment-Based Drug Discovery Market, By End-User, 2023 (US$ Million)
2.5. Global Fragment-Based Drug Discovery Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023

3. Fragment-Based Drug Discovery Market: Competitive Analysis
3.1. Market Positioning of Key Fragment-Based Drug Discovery Market Vendors
3.2. Strategies Adopted by Fragment-Based Drug Discovery Market Vendors
3.3. Key Industry Strategies
4. Fragment-Based Drug Discovery Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Fragment-Based Drug Discovery Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Fragment Screening
5.3.1.1. Biophysical Techniques
5.3.1.1.1. NMR Spectroscopy
5.3.1.1.2. Differential Scanning Fluorimetry (DSF) Assay
5.3.1.1.3. Fluorescence Polarization
5.3.1.1.4. Isothermal Titration Calorimetry
5.3.1.1.5. X-ray Crystallography
5.3.1.1.6. Surface Plasmon Resonance (SPR)
5.3.1.1.7. Bilayer Interferometry
5.3.1.1.8. Mass Spectrometry (MS)
5.3.1.1.9. Capillary Electrophoresis
5.3.1.1.10. Weak Affinity Chromatography (WAC - HPLC-UV/MS)
5.3.1.1.11. Other assays (biochemical)
5.3.1.2. Non-biophysical Techniques
5.3.2. Fragment Optimization

6. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Oncology
6.3.2. Central Nervous System (CNS) Disorders
6.3.3. Infectious Diseases
6.3.4. Cardiovascular Diseases
6.3.5. Metabolic Disorders
6.3.6. Inflammation & Autoimmune Diseases

7. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Academic & Research Institutions
7.3.2. Pharmaceutical & Biotechnology Companies
7.3.3. Contract Research Organizations (CROs)

8. North America Fragment-Based Drug Discovery Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
8.3. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
8.4. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
8.5.Fragment-Based Drug Discovery Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
8.5.1.1.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
8.5.1.1.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
8.5.1.2.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
8.5.1.2.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
8.5.1.3.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
8.5.1.3.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)

9. UK and European Union Fragment-Based Drug Discovery Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
9.3. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
9.4. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
9.5.Fragment-Based Drug Discovery Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
9.5.1.1.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
9.5.1.1.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
9.5.1.2.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
9.5.1.2.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
9.5.1.3.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
9.5.1.3.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
9.5.1.4.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
9.5.1.4.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
9.5.1.5.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
9.5.1.5.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
9.5.1.6.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
9.5.1.6.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)

10. Asia Pacific Fragment-Based Drug Discovery Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
10.3. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
10.4. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
10.5.Fragment-Based Drug Discovery Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
10.5.1.1.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
10.5.1.1.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
10.5.1.2.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
10.5.1.2.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
10.5.1.3.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
10.5.1.3.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
10.5.1.4.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
10.5.1.4.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
10.5.1.5.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
10.5.1.5.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
10.5.1.6.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
10.5.1.6.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)

11. Latin America Fragment-Based Drug Discovery Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
11.3. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
11.4. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
11.5.Fragment-Based Drug Discovery Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
11.5.1.1.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
11.5.1.1.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
11.5.1.2.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
11.5.1.2.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
11.5.1.3.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
11.5.1.3.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)

12. Middle East and Africa Fragment-Based Drug Discovery Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
12.3. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
12.4. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
12.5.Fragment-Based Drug Discovery Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
12.5.1.1.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
12.5.1.1.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
12.5.1.2.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
12.5.1.2.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Fragment-Based Drug Discovery Market: By Component, 2022-2032, USD (Million)
12.5.1.3.2. Fragment-Based Drug Discovery Market: By Application, 2022-2032, USD (Million)
12.5.1.3.3. Fragment-Based Drug Discovery Market: By End-User, 2022-2032, USD (Million)

13. Company Profile
13.1. Pfizer Inc.
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Novartis AG
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Johnson & Johnson
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Alveus Pharmaceuticals Pvt. Ltd.
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Astex Pharmaceuticals
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Charles River Laboratories International, Inc.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Beactica AB
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Emerald BioStructures, Inc.
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Crown Bioscience, Inc.
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Evotec AG
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Proteros Fragments GmbH
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Kinetic Discovery Limited
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. Sprint Bioscience
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives
13.14. Sygnature Discovery
13.14.1. Company Overview
13.14.2. Financial Performance
13.14.3. Product Portfolio
13.14.4. Strategic Initiatives
13.15. Structure Based Design, Inc
13.15.1. Company Overview
13.15.2. Financial Performance
13.15.3. Product Portfolio
13.15.4. Strategic Initiatives
13.16. Other Notable Players
13.16.1. Company Overview
13.16.2. Financial Performance
13.16.3. Product Portfolio
13.16.4. Strategic Initiatives